- Home » News and Events

NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
Dec 7, 2020
Passage Bio, Inc. and Catalent today announced that manufacturing operations have commenced to support adeno-associated virus (AAV) production for Passage Bio’s lead gene therapy product candidates for the treatment of rare monogenic CNS disorders.
Catalent Appoints Dr. Behzad Mahdavi as Vice President of Open Innovation, Biologics, Cell and Gene Therapy
Nov 19, 2020
Catalent appoints Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy. Dr. Mahdavi will join a team of experts to accelerate the adoption of new development and drug delivery technologies, and scalable manufacturing processes and techniques.
Catalent Completes Acquisition of Cell Therapy Manufacturing Facility from Bone Therapeutics
Nov 16, 2020
Catalent has completed the acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support SA (SCTS), including all of its assets located in Gosselies, Belgium.
Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent
Nov 5, 2020
Taysha Gene Therapies and Catalent today announced a partnership to support the development and manufacturing of Taysha’s gene therapies at Catalent’s Maryland-based gene therapy facilities.
Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn®
Oct 22, 2020
Catalent and BrainStorm Cell Therapeutics Inc announced an agreement for the manufacture of NurOwn®, BrainStorm’s autologous cellular therapy being investigated for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or motor neuron disease.
Catalent to Discuss Innovative Approaches to Achieving T-Cell Commercial Readiness at Upcoming Industry Conference
Oct 12, 2020
Catalent today announced that Jesse Trekker, Ph.D., Business Director, Strategic Partnerships, Catalent Cell & Gene Therapy, will present at the Allogeneic Cell Therapies Summit, which will take place virtually on 26 – 28 October, 2020.
Innovation in Oncology, Cell & Gene Technology, and Post-COVID-19 Pharma Outlook to be Discussed by Catalent at CPhI
Oct 6, 2020
Catalent today announced that it will be participating in several roundtables alongside other leading industry experts at the CPhI Festival of Pharma, which is taking place virtually between Oct. 5 – 16, 2020.
Catalent Acquires New Biologics Facility to Create North American Clinical Manufacturing Center of Excellence
Sep 24, 2020
Catalent today announced that it has acquired a new manufacturing facility in Bloomington, Indiana, to create a North American center of excellence for early-phase clinical biologics formulation development and drug product fill/finish services.
Advantages of Oncolytic Viruses as Immunotherapies to be Discussed by Catalent Gene Therapy Expert at World Vaccine Congress
Sep 22, 2020
Catalent today announced that George Buchman, Ph.D., Vice President, Preclinical & Process Development, will present at the World Vaccine Congress, which will take place virtually on Sept. 28 – October 1, 2020.
Webinar: Are Real-Time Gene Therapy Test Results Possible?
Date: January 26, 2021
WCBP 2021
Date: January 25-28 – February 1-4, 2021
Navigating the Path to the Clinic and Beyond for Gene Therapies
Date: February 2, 2021
CAR-TCR Digital Summit Europe
Date: February 16-18, 2021
Gene Therapy for Rare Disorders
Date: February 22-25, 2021
Early Phase Biologic Development: Upstream and Downstream Processes Considerations
Date: February 23, 2021
ISBiotech – 10th Spring Meeting Redux
Date: March 15-17, 2021
BEBPA US Bioassay Conference
Date: March 22-25, 2021
Cell Gene Meeting on the Med
Date: April 6-9, 2021
World ADC Europe 2021
Date: March 8-11, 2021
CASSS Bioassays Symposium 2021
Date: April 19-23 2021
PEGS Boston 2021
Date: May 11-13, 2021
ASGCT 24th Annual Meeting
Date: May 12-15, 2021
ISCT 2021
Date: May 26-28, 2021
Phacilitate – Advanced Therapies Week
Date: June 6-8, 2021
BIO International 2021
Date: June 14-17, 2021
CAR-TCR Summit Boston 2021
Date: August 31-September 2, 2021
Cell Culture Engineering XVII
Date: October 17-22, 2021